Skip to main content
NVDA-0.10%AAPL+0.95%GOOGL-2.28%MSFT+0.10%AMZN+0.12%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.93%TSLA-0.43%SKHY+7.05%MU-1.41%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.80%0005.HK-0.78%HSBA.L-1.75%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.25%CHFJPY-1.73%USDJPY-1.63%AUDJPY-1.51%EURJPY-1.43%CADJPY-1.41%GBPJPY-1.38%GBPNZD+0.87%EURNZD+0.85%NZDCAD-0.85%AUDNZD+0.76%NZDUSD-0.65%NZDCHF-0.55%GBPTRY+0.41%GBPCHF+0.34%GBPHKD+0.32%CADCHF+0.30%EURCHF+0.30%GBPMXN-0.28%EURNOK+0.28%EURZAR+0.25%USDNOK+0.25%GBPUSD+0.24%GBPZAR+0.24%USDZAR+0.23%AUDCHF+0.22%USDCAD-0.20%EURUSD+0.19%CHFNOK+0.19%AUDNOK+0.16%NZDSGD+0.16%USDILS+0.16%EURSEK+0.15%NOKJPY-0.14%AUDCAD-0.12%USDSEK+0.12%USDCHF+0.12%AUDDKK-0.11%NZDMXN+0.11%GBPAUD+0.11%USDTRY+0.11%AUDUSD+0.11%EURSGD+0.10%GBPSGD+0.09%EURAUD+0.09%USDSGD+0.08%PLNJPY+0.08%USDTHB+0.08%EURCZK-0.06%CHFSEK+0.06%EURPLN+0.06%USDMXN+0.05%USDCOP-0.04%USDPLN+0.03%SGDJPY+0.03%EURGBP-0.03%USDCNH-0.03%USDDKK-0.02%EURCNH+0.02%EURCAD-0.02%GBPCAD+0.02%CHFSGD+0.01%EURHKD+0.01%USDHKD+0.01%AUDSGD-0.01%EURDKK0.00%COFFEE-1.93%XPTUSD-1.78%SUGAR+1.74%COTTON+1.05%GAGUSD-0.96%XAGUSD-0.96%COCOA-0.93%USOIL+0.70%UKOIL+0.59%S1+0.52%HG1-0.52%C1+0.48%BTCUSD-0.21%ETHUSD+0.28%USDTUSD-0.06%XRPUSD-0.98%SOLUSD-0.31%TRXUSDT+0.39%ZECUSDT-1.53%DOGEUSD-1.18%XMRUSDT-0.24%LINKUSD+0.04%XLMUSD-0.68%BCHUSDT-1.65%LTCUSD-1.40%UNIUSD-1.96%TONUSD+24.88%HBARUSDT-0.99%SUIUSD-0.93%TAOUSDT-0.42%AAVEUSD-1.17%DOTUSDT-1.65%ICPUSDT-0.68%ONDOUSDT-1.67%WLDUSDT-1.47%ATOMUSDT-1.89%ARBUSDT-0.64%JUPUSDT-2.53%INJUSDT-1.83%STXUSDT-2.70%FETUSDT-2.03%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.52%IMXUSDT-1.48%WIFUSDT-2.44%GRTUSDT-2.03%OPUSDT-1.99%POLUSDT-1.38%IOTAUSDT-1.91%AXSUSDT-1.60%FARTCOINUSDT-1.00%EOSUSDT-0.19%DYDXUSDT+0.05%ORDIUSDT+1.47%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.10%AAPL+0.95%GOOGL-2.28%MSFT+0.10%AMZN+0.12%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.93%TSLA-0.43%SKHY+7.05%MU-1.41%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.80%0005.HK-0.78%HSBA.L-1.75%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.25%CHFJPY-1.73%USDJPY-1.63%AUDJPY-1.51%EURJPY-1.43%CADJPY-1.41%GBPJPY-1.38%GBPNZD+0.87%EURNZD+0.85%NZDCAD-0.85%AUDNZD+0.76%NZDUSD-0.65%NZDCHF-0.55%GBPTRY+0.41%GBPCHF+0.34%GBPHKD+0.32%CADCHF+0.30%EURCHF+0.30%GBPMXN-0.28%EURNOK+0.28%EURZAR+0.25%USDNOK+0.25%GBPUSD+0.24%GBPZAR+0.24%USDZAR+0.23%AUDCHF+0.22%USDCAD-0.20%EURUSD+0.19%CHFNOK+0.19%AUDNOK+0.16%NZDSGD+0.16%USDILS+0.16%EURSEK+0.15%NOKJPY-0.14%AUDCAD-0.12%USDSEK+0.12%USDCHF+0.12%AUDDKK-0.11%NZDMXN+0.11%GBPAUD+0.11%USDTRY+0.11%AUDUSD+0.11%EURSGD+0.10%GBPSGD+0.09%EURAUD+0.09%USDSGD+0.08%PLNJPY+0.08%USDTHB+0.08%EURCZK-0.06%CHFSEK+0.06%EURPLN+0.06%USDMXN+0.05%USDCOP-0.04%USDPLN+0.03%SGDJPY+0.03%EURGBP-0.03%USDCNH-0.03%USDDKK-0.02%EURCNH+0.02%EURCAD-0.02%GBPCAD+0.02%CHFSGD+0.01%EURHKD+0.01%USDHKD+0.01%AUDSGD-0.01%EURDKK0.00%COFFEE-1.93%XPTUSD-1.78%SUGAR+1.74%COTTON+1.05%GAGUSD-0.96%XAGUSD-0.96%COCOA-0.93%USOIL+0.70%UKOIL+0.59%S1+0.52%HG1-0.52%C1+0.48%BTCUSD-0.21%ETHUSD+0.28%USDTUSD-0.06%XRPUSD-0.98%SOLUSD-0.31%TRXUSDT+0.39%ZECUSDT-1.53%DOGEUSD-1.18%XMRUSDT-0.24%LINKUSD+0.04%XLMUSD-0.68%BCHUSDT-1.65%LTCUSD-1.40%UNIUSD-1.96%TONUSD+24.88%HBARUSDT-0.99%SUIUSD-0.93%TAOUSDT-0.42%AAVEUSD-1.17%DOTUSDT-1.65%ICPUSDT-0.68%ONDOUSDT-1.67%WLDUSDT-1.47%ATOMUSDT-1.89%ARBUSDT-0.64%JUPUSDT-2.53%INJUSDT-1.83%STXUSDT-2.70%FETUSDT-2.03%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.52%IMXUSDT-1.48%WIFUSDT-2.44%GRTUSDT-2.03%OPUSDT-1.99%POLUSDT-1.38%IOTAUSDT-1.91%AXSUSDT-1.60%FARTCOINUSDT-1.00%EOSUSDT-0.19%DYDXUSDT+0.05%ORDIUSDT+1.47%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
CO

CorMedix Inc. (CRMD)

NASDAQ • Healthcare

$8.13
-$0.04 (-0.6%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$8.18
Day Range$8.08 - $8.33
Avg. Volume (3M)1.4M
Market Cap$637.8M
P/E Ratio3.4
52 Week Range
$6.13$13.34
Next EarningsIn 62 daysNov 11, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$101.9M100%
Gross Profitminus cost of goods$77.1M76%
Operating Incomeminus R&D and overhead$42.9M42%
Net Incomeminus taxes and the rest$25.9M25%

In plain terms: out of every $100 in revenue, CorMedix Inc. keeps $25 as net profit.

Fundamentals & Financials

Revenue (TTM)
$462.2M
Net Income (TTM)
$187.1M
EPS (TTM)
$2.41
ROA (TTM)
20.7%
Current Ratio
2.56
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-79.1%Q1 2026$0.18
+22.9%Q2 2026$0.43
+21.8%Q3 2026$0.29
Next

Nov 11

in 62 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About CorMedix Inc.

CorMedix Inc. (NASDAQ: CRMD) is a healthcare biotechnology company centered on DefenCath/Neutrolin, an anti-infective solution used to protect catheter patients from infection and clotting. In FY2025, the company generated $311.7 million in revenue. CorMedix serves the United States and international markets from a business built around this single product platform.

Name
CorMedix Inc.
CEO
Joseph Todisco
Website
www.cormedix.com
Industry
Healthcare
Year Founded
2006
Employees
191

Today's Snapshot

AI-generated

CRMD closed 0.6% below yesterday's close, while its sector was flat. CorMedix presented at a healthcare conference hosted by Wells Fargo, a bank, discussing growth and risks.

Trading Volume

Above 10d avg 882.1K

927.1K

vs S&P 500 Today

Moderate Underperformance

-0.19%

Updated: September 9, 2026 at 20:19 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
CRMD is quoted at 8.13 with a mixed technical profile: ADX near 28 signals a developing trend, yet short-term momentum readings are weak and the 10- and 20-period averages sit above the market, weighing on near-term price action. Longer-term averages are mixed and the 200-day measures are slightly higher, underscoring recent weakness. Volume metrics are negative and ATR is modest at roughly 4.2 percent, with the pivot near current levels. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$8.09 - $8.67
    Sell
  • RSI (14)49.45
    Neutral
  • Stochastic %K (14, 3, 3)32.61
    Neutral
  • MACD Level (12, 26)0.12
    Neutral

Peers & Related Assets

TNGXTango Therapeutics, Inc.
$24+5.7%
PVLAPalvella Therapeutics, Inc.
$151.34-0.6%
SEPNSepterna Inc
$37.97+1.6%
BCAXBicara Therapeutics Inc. Common Stock
$23.64-0.3%
SVRASavara Inc.
$5.42-2.0%
KURAKura Oncology, Inc.
$12.09-3.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.